3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
3
Diabetes Mellitus
2
Vomiting
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Prostatic Neoplasms
1
Premature Birth
1
Pre-Eclampsia
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Neoplasms
1
Medulloblastoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia, B-Cell
1
Leiomyosarcoma
1
Hyperparathyroidism, Primary
1
Hot Flashes
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Erectile Dysfunction
1
Cognitive Dysfunction
1
Carcinoma, Renal Cell
1
Interventions
liposomal amphotericin B
2
Early Intervention, Educational
2
immunotoxin HA22
1
ferrous sulfate
1
ferric gluconate
1
Verapamil
1
Vancomycin
1
Valacyclovir
1
Therapeutics
1
Tazobactam
1
Tablets
1
Sucrose
1
Ribavirin
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Piperacillin, Tazobactam Drug Combination
1
Piperacillin
1
Pharmacogenomic Testing
1
Peripheral Blood Stem Cell Transplantation
1
Palivizumab
1
Ondansetron
1
Moxifloxacin
1
Morphine
1
Levofloxacin
1
Ketamine
1
Itraconazole
1
Hypericum extract LI 160
1
Fluconazole
1
Fentanyl
1
Dextromethorphan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, Hairy Cell
×
Tablets
×
Clear all
NCT04233034
2024-11-27
CLVer
Jaeb Center for Health Research
Phase 3
Completed
113 enrolled
42 charts